T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors
Research output: Contribution to journal › Article › peer-review
4Citations
(Scopus)
Fingerprint
Dive into the research topics of 'T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors'. Together they form a unique fingerprint.